Worldwide Daily COVID-19 Deaths Surpass 10,000 for the First Time in History View original image


[Asia Economy Reporter Park Jong-il] The global daily death toll from COVID-19 has surpassed 10,000 for the first time ever (according to international statistics site Worldometer as of the 12th).


In particular, the situation in the United States and Europe, with winter approaching, is becoming increasingly severe.


According to statistics from Johns Hopkins University the previous day, the daily death toll in the U.S. exceeded 2,000 for the first time in six months. On the same day, The Washington Post reported 145,835 new daily cases, 64,000 hospitalized COVID-19 patients, with over 3,000 in critical condition.


The White House recently warned in a report that "community spread of COVID-19 is accelerating in half of the regions in the United States."


In the UK, which has a population similar to South Korea, COVID-19 deaths have surged, surpassing 50,000 cumulative deaths for the first time in Europe. Italy recorded a cumulative 1.02 million cases yesterday, nine months after its first confirmed case in February. France, with 60,000 new daily cases, already has full hospital capacity and is transporting patients by jet 500 km away to Germany. Russia recorded a daily death toll exceeding 430, its highest ever, and Japan, which postponed the Olympics due to COVID-19, recorded a record high of 1,635 deaths the previous day.


Tomorrow marks 300 days since the first confirmed case in South Korea. Sporadic cluster infections continue not only in vulnerable hospitals and nursing facilities but also in everyday spaces such as families, gatherings, and academies. As of midnight on the 13th, 191 new domestic cases were reported, close to 200, marking six consecutive days of triple-digit cases. Health authorities predict that if this spread continues, social distancing measures may need to be raised from level 1 to 1.5 within 2 to 3 weeks.


Meanwhile, the Ministry of Food and Drug Safety officially approved antigen and antibody tests on the 11th, which, although slightly less accurate than diagnostic tests, can deliver results within 30 minutes. These tests are expected to be useful for medical staff and workers in nursing facilities and workplaces dealing with many people.


For the principle of infectious disease response, "early detection, early containment," proactive specimen testing is most important. Gangnam-gu conducted specimen testing based on this principle from the early stages of the outbreak, surpassing 70,000 tests last week and identifying 135 asymptomatic infected individuals who could have been "silent spreaders," effectively preventing further transmission.


Reflecting on the past 10 months since the third confirmed case in South Korea visited Gangnam-gu on January 26, it is clear that infectious disease management requires differentiated response strategies based on regional characteristics and rapid initial response. To this end, Gangnam-gu opened the nation's first "Smart Infectious Disease Management Center" on this day.


The Smart Infectious Disease Management Center, an expanded and reorganized version of the Gangnam-gu Public Health Center screening clinic, is a standalone building equipped with negative pressure examination rooms. It will have infectious disease specialists, epidemiologists, and other professionals on standby to focus on managing vulnerable groups such as overseas arrivals and the elderly.


Gangnam-gu staff pledge to continue their best efforts to establish a safe management system free from infectious disease concerns.


Confirmed Cases Status


Gangnam-gu reported one additional case today, bringing the cumulative total to 390. Case number 390 is a family member of a previously confirmed Gangnam-gu resident and tested positive at the Gangnam-gu Public Health Center.


Self-Quarantine Status


Currently, Gangnam-gu is managing 883 individuals in self-quarantine, including 707 overseas arrivals and 176 domestic contacts.


Number of Specimen Tests


The cumulative number of specimen tests conducted at the Gangnam-gu Public Health Center screening clinic is 77,300. Of the 534 tests conducted the previous day, 89 were overseas arrivals and 479 were domestic residents.


According to the COVID-19 vaccine candidate status published by the World Health Organization (WHO) the previous day, 48 vaccine candidates worldwide are undergoing clinical trials, with 10 in the final Phase 3 stage. German company BioNTech, developing a vaccine with U.S. pharmaceutical company Pfizer, recently announced that their Phase 3 clinical trial vaccine has over 90% efficacy, raising expectations. Meanwhile, the South Korean government has announced plans to secure enough COVID-19 vaccines to cover 60% of the population within this year, attracting attention.


From today, a fine of 100,000 KRW will be imposed for not wearing masks properly in public transportation and other multi-use facilities. Mask-wearing is mandatory in 23 locations including restaurants, bars, karaoke rooms, cafes, academies, and public transportation. Facility managers or operators who fail to post or provide guidance on quarantine guidelines may face fines up to 3 million KRW.


Gangnam-gu has formed a special team of 157 members to guide proper mask-wearing mainly at multi-use facilities such as subway stations and bus stops within the district.


In line with Seoul City's policy, a "24-hour Mask Complaint Handling Emergency Response Team" capable of consultation and on-site dispatch will operate for two weeks until the 27th to enforce mask regulations.



District Mayor Jung Soon-gyun stated, "I ask all residents to remember that sincere compliance with quarantine rules is the best 'preventive vaccine' to stop the spread of the virus."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing